Business Context and Reporting Period
Company: Oragenics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 5, 2008 (Event Date: May 13, 2008)
Context: The filing discloses an upcoming corporate name change. The Company announced it intends to change its name to "ONI BioPharma Inc." pending formal shareholder approval.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report regarding a corporate event rather than a periodic financial report.
Material Changes
- Corporate Identity: The Company plans to adopt the new name "ONI BioPharma Inc."
- Interim Usage: The new name will be used in communications until the name change is formally approved by shareholders.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) detailing the name change strategy. No specific financial guidance, operational outlook, or risk factors are disclosed in this specific 8-K text.
Key Facts for Investor Verification
- Verify the status of the shareholder vote required to formally approve the name change to "ONI BioPharma Inc."
- Review the attached press release (Exhibit 99.1) for the strategic rationale behind the rebranding.
- Confirm the effective date of the name change on stock exchanges and regulatory filings.